409 related articles for article (PubMed ID: 30315348)
1. Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer.
Weinstein AM; Giraldo NA; Petitprez F; Julie C; Lacroix L; Peschaud F; Emile JF; Marisa L; Fridman WH; Storkus WJ; Sautès-Fridman C
Cancer Immunol Immunother; 2019 Jan; 68(1):109-120. PubMed ID: 30315348
[TBL] [Abstract][Full Text] [Related]
2. IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses.
Wang X; Zhao X; Feng C; Weinstein A; Xia R; Wen W; Lv Q; Zuo S; Tang P; Yang X; Chen X; Wang H; Zang S; Stollings L; Denning TL; Jiang J; Fan J; Zhang G; Zhang X; Zhu Y; Storkus W; Lu B
Cancer Cell; 2015 Sep; 28(3):296-306. PubMed ID: 26321222
[TBL] [Abstract][Full Text] [Related]
3. IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?
Chen F; Qu M; Zhang F; Tan Z; Xia Q; Hambly BD; Bao S; Tao K
BMC Cancer; 2020 Feb; 20(1):92. PubMed ID: 32013927
[TBL] [Abstract][Full Text] [Related]
4. Human NKp44
Ikeda A; Ogino T; Kayama H; Okuzaki D; Nishimura J; Fujino S; Miyoshi N; Takahashi H; Uemura M; Matsuda C; Yamamoto H; Takeda K; Mizushima T; Mori M; Doki Y
Cancer Immunol Res; 2020 Jun; 8(6):724-731. PubMed ID: 32229590
[TBL] [Abstract][Full Text] [Related]
5. Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs.
Hewitt SL; Bai A; Bailey D; Ichikawa K; Zielinski J; Karp R; Apte A; Arnold K; Zacharek SJ; Iliou MS; Bhatt K; Garnaas M; Musenge F; Davis A; Khatwani N; Su SV; MacLean G; Farlow SJ; Burke K; Frederick JP
Sci Transl Med; 2019 Jan; 11(477):. PubMed ID: 30700577
[TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
[TBL] [Abstract][Full Text] [Related]
7. CD86
Wennhold K; Thelen M; Lehmann J; Schran S; Preugszat E; Garcia-Marquez M; Lechner A; Shimabukuro-Vornhagen A; Ercanoglu MS; Klein F; Thangarajah F; Eidt S; Löser H; Bruns C; Quaas A; von Bergwelt-Baildon M; Schlößer HA
Cancer Immunol Res; 2021 Sep; 9(9):1098-1108. PubMed ID: 34155067
[TBL] [Abstract][Full Text] [Related]
8. The Crohn's-Like Lymphoid Reaction to Colorectal Cancer-Tertiary Lymphoid Structures With Immunologic and Potentially Therapeutic Relevance in Colorectal Cancer.
Maoz A; Dennis M; Greenson JK
Front Immunol; 2019; 10():1884. PubMed ID: 31507584
[TBL] [Abstract][Full Text] [Related]
9. Tertiary Lymphoid Structures in Colorectal Cancer Liver Metastases: Association With Immunological and Clinical Parameters and Chemotherapy Response.
Ahmed A; Halama N
Anticancer Res; 2020 Nov; 40(11):6367-6373. PubMed ID: 33109574
[TBL] [Abstract][Full Text] [Related]
10. The Immunosuppressive Niche of Soft-Tissue Sarcomas is Sustained by Tumor-Associated Macrophages and Characterized by Intratumoral Tertiary Lymphoid Structures.
Chen L; Oke T; Siegel N; Cojocaru G; Tam AJ; Blosser RL; Swailes J; Ligon JA; Lebid A; Morris C; Levin A; Rhee DS; Johnston FM; Greer JB; Meyer CF; Ladle BH; Thompson ED; Montgomery EA; Choi W; McConkey DJ; Anders RA; Pardoll DM; Llosa NJ
Clin Cancer Res; 2020 Aug; 26(15):4018-4030. PubMed ID: 32332015
[TBL] [Abstract][Full Text] [Related]
11. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.
Zhang Y; Davis C; Shah S; Hughes D; Ryan JC; Altomare D; Peña MM
Mol Carcinog; 2017 Jan; 56(1):272-287. PubMed ID: 27120577
[TBL] [Abstract][Full Text] [Related]
12. Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment.
Weinstein AM; Chen L; Brzana EA; Patil PR; Taylor JL; Fabian KL; Wallace CT; Jones SD; Watkins SC; Lu B; Stroncek DF; Denning TL; Fu YX; Cohen PA; Storkus WJ
Oncoimmunology; 2017; 6(6):e1322238. PubMed ID: 28680760
[TBL] [Abstract][Full Text] [Related]
13. Role of LAP
Zhong W; Jiang ZY; Zhang L; Huang JH; Wang SJ; Liao C; Cai B; Chen LS; Zhang S; Guo Y; Cao YF; Gao F
World J Gastroenterol; 2017 Jan; 23(3):455-463. PubMed ID: 28210081
[TBL] [Abstract][Full Text] [Related]
14. Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.
Narayanan S; Kawaguchi T; Yan L; Peng X; Qi Q; Takabe K
Ann Surg Oncol; 2018 Aug; 25(8):2323-2331. PubMed ID: 29770915
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis.
Bozoyan L; Dumas A; Patenaude A; Vallières L
J Neuroinflammation; 2015 Sep; 12():173. PubMed ID: 26377915
[TBL] [Abstract][Full Text] [Related]
16. IL-36γ induces a transient HSV-2 resistant environment that protects against genital disease and pathogenesis.
Gardner JK; Herbst-Kralovetz MM
Cytokine; 2018 Nov; 111():63-71. PubMed ID: 30118914
[TBL] [Abstract][Full Text] [Related]
17. IL-36γ and IL-36Ra Reciprocally Regulate Colon Inflammation and Tumorigenesis by Modulating the Cell-Matrix Adhesion Network and Wnt Signaling.
Yang W; Dong HP; Wang P; Xu ZG; Xian J; Chen J; Wu H; Lou Y; Lin D; Zhong B
Adv Sci (Weinh); 2022 Apr; 9(10):e2103035. PubMed ID: 35119210
[TBL] [Abstract][Full Text] [Related]
18. IL-36 Signaling in the Tumor Microenvironment.
Chelvanambi M; Weinstein AM; Storkus WJ
Adv Exp Med Biol; 2020; 1240():95-110. PubMed ID: 32060891
[TBL] [Abstract][Full Text] [Related]
19. Increased CD8 Tumor Infiltrating Lymphocytes in Colorectal Cancer Microenvironment Supports an Adaptive Immune Resistance Mechanism of PD-L1 Expression.
Sudoyo AW; Kurniawan AN; Kusumo GD; Putra TP; Rexana FA; Yunus M; Budiyati AD; Kurniawan D; Utama A; Utomo AR
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3421-3427. PubMed ID: 31759368
[TBL] [Abstract][Full Text] [Related]
20. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer.
Ge P; Wang W; Li L; Zhang G; Gao Z; Tang Z; Dang X; Wu Y
Biomed Pharmacother; 2019 Oct; 118():109228. PubMed ID: 31351430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
